Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Enochian Biosciences Inc.

    NASDAQ: ENOB · Real-Time Price · USD
    0.71
    0.01 (1.43%)
    At close: Aug 04, 2023, 9:58 PM

    Enochian Biosciences Statistics

    Share Statistics

    Enochian Biosciences has 63.7M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 63.7M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 27.81M

    Failed to Deliver (FTD) Shares

    n/a
    		 18,870

    FTD / Avg. Volume

    n/a
    		 7.41%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -1.86 and the forward PE ratio is null. Enochian Biosciences's PEG ratio is -0.1.

    PE Ratio

    n/a
    		 -1.86

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 1.14

    P/FCF Ratio

    n/a
    		 -13.6

    PEG Ratio

    n/a
    		 -0.1
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Enochian Biosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.07, with a Debt / Equity ratio of 0.03.

    Current Ratio

    n/a
    		 0.07

    Quick Ratio

    n/a
    		 0.07

    Debt / Equity

    n/a
    		 0.03

    Debt / EBITDA

    n/a
    		 -0.05

    Debt / FCF

    n/a
    		 -0.34

    Interest Coverage

    n/a
    		 -80.73

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-3,665,916.86

    Employee Count

    n/a
    		 22

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -72.69% in the last 52 weeks. The beta is 0.94, so Enochian Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.94

    52-Week Price Change

    n/a
    		 -72.69%

    50-Day Moving Average

    n/a
    		 0.97

    200-Day Moving Average

    n/a
    		 1.11

    Relative Strength Index (RSI)

    n/a
    		 77.82

    Average Volume (20 Days)

    n/a
    		 254,603

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -121.86K

    Operating Income

    n/a
    		 -81.64M

    Net Income

    n/a
    		 -80.65M

    EBITDA

    n/a
    		 -79.52M

    EBIT

    n/a
    		 -79.64M

    Earnings Per Share (EPS)

    n/a
    		 -0.84
    Full Income Statement

    Balance Sheet

    The company has 220.47K in cash and 3.79M in debt, giving a net cash position of -3.57M.

    Cash & Cash Equivalents

    n/a
    		 220.47K

    Total Debt

    n/a
    		 3.79M

    Net Cash

    n/a
    		 -3.57M

    Retained Earnings

    n/a
    		 -324.68M

    Total Assets

    n/a
    		 58,018.1B

    Working Capital

    n/a
    		 -11,355.2B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -10.97M and capital expenditures -70.43K, giving a free cash flow of -11.04M.

    Operating Cash Flow

    n/a
    		 -10.97M

    Capital Expenditures

    n/a
    		 -70.43K

    Free Cash Flow

    n/a
    		 -11.04M

    FCF Per Share

    n/a
    		 -0.11
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ENOB does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for ENOB.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -8.75

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist